IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 695 
Small font sizeDefault font sizeIncrease font size
Read this article

 


    Article Cited by others

EDUCATIONAL FORUM

Inverse agonism and its therapeutic significance

Khilnani Gurudas, Khilnani Ajeet Kumar

Year : 2011| Volume: 43| Issue : 5 | Page no: 492-501

   This article has been cited by
 
1 Involvement of Histamine 2 Receptor in Alpha 1 Adrenoceptor Mediated Cardiac Hypertrophy and Oxidative Stress in H9c2 Cardio Myoblasts
Ajay Godwin Potnuri, Lingesh Allakonda, Sherin Saheera
Journal of Cardiovascular Translational Research. 2021; 14(1): 184
[Pubmed]  [Google Scholar] [DOI]
2 Adrenal angiotensin II type 1 receptor biased signaling: The case for “biased” inverse agonism for effective aldosterone suppression
Krysten E. Ferraino, Natalie Cora, Celina M. Pollard, Anastasiya Sizova, Jennifer Maning, Anastasios Lymperopoulos
Cellular Signalling. 2021; 82: 109967
[Pubmed]  [Google Scholar] [DOI]
3 Therapeutic Properties of Highly Selective ß-blockers With or Without Additional Vasodilator Properties: Focus on Bisoprolol and Nebivolol in Patients With Cardiovascular Disease
Waleed AlHabeeb, Sanaa Mrabeti, Ahmed Adel Ibrahim Abdelsalam
Cardiovascular Drugs and Therapy. 2021;
[Pubmed]  [Google Scholar] [DOI]
4 Critical role of Aquaporin-1 and telocytes in infantile hemangioma response to propranolol beta blockade
François Moisan, Sandra Oucherif, Priscilla Kaulanjan-Checkmodine, Sorilla Prey, Benoît Rousseau, Marc Bonneu, Stéphane Claverol, Etienne Gontier, Sabrina Lacomme, Lea Dousset, Thierry Couffinhal, Jerome Toutain, Maya Loot, Muriel Cario-André, Marie-Laure Jullié, Christine Léauté-Labrèze, Alain Taieb, Hamid Reza Rezvani
Proceedings of the National Academy of Sciences. 2021; 118(7): e201869011
[Pubmed]  [Google Scholar] [DOI]
5 ß-Blockade for Patients with Hypertension, Ischemic Heart Disease or Heart Failure: Where are We Now?
Atul Pathak, Sanaa Mrabeti
Vascular Health and Risk Management. 2021; Volume 17: 337
[Pubmed]  [Google Scholar] [DOI]
6 d Opioid Receptor Inverse Agonists and their In Vivo Pharmacological Effects
Shigeto Hirayama , Hideaki Fujii
Current Topics in Medicinal Chemistry. 2020; 20(31): 2889
[Pubmed]  [Google Scholar] [DOI]
7 Synthesis of anti-allergic drugs
Shiyang Zhou, Gangliang Huang
RSC Advances. 2020; 10(10): 5874
[Pubmed]  [Google Scholar] [DOI]
8 The antagonistic activity of H1 receptor antagonists as medicinal foods
Shiyang Zhou, Gangliang Huang, Guangying Chen
Trends in Food Science & Technology. 2020; 105: 1
[Pubmed]  [Google Scholar] [DOI]
9 Discovery of d Opioid Receptor Full Inverse Agonists and Their Effects on Restraint Stress-Induced Cognitive Impairment in Mice
Shigeto Hirayama, Takashi Iwai, Eika Higashi, Minami Nakamura, Chiharu Iwamatsu, Kennosuke Itoh, Toru Nemoto, Mitsuo Tanabe, Hideaki Fujii
ACS Chemical Neuroscience. 2019; 10(5): 2237
[Pubmed]  [Google Scholar] [DOI]
10 Chronic diphenhydramine abuse and withdrawal
Jagroop S. Saran, Richard L. Barbano, Rachel Schult, Timothy J. Wiegand, Olga Selioutski
Neurology: Clinical Practice. 2017; 7(5): 439
[Pubmed]  [Google Scholar] [DOI]
11 Candesartan Improves Ischemia-Induced Impairment of the Blood–Brain Barrier In Vitro
Gohei So,Shinsuke Nakagawa,Yoichi Morofuji,Takeshi Hiu,Kentaro Hayashi,Kunihiko Tanaka,Kazuhiko Suyama,Maria A. Deli,Izumi Nagata,Takayuki Matsuo,Masami Niwa
Cellular and Molecular Neurobiology. 2014;
[Pubmed]  [Google Scholar] [DOI]
12 Pimavanserin for the treatment of Parkinsonæs disease psychosis
Joseph H Friedman
Expert Opinion on Pharmacotherapy. 2013; 14(14): 1969
[Pubmed]  [Google Scholar] [DOI]

 

Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer
Online since 20th July '04
Published by Wolters Kluwer - Medknow